A detailed history of Capital International, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital International, Inc. holds 50,934 shares of NVO stock, worth $4.52 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
50,934
Previous 50,023 1.82%
Holding current value
$4.52 Million
Previous $7.14 Million 15.07%
% of portfolio
0.08%
Previous 0.1%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $108,472 - $132,477
911 Added 1.82%
50,934 $6.06 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $561,889 - $672,700
4,579 Added 10.08%
50,023 $7.14 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $503,606 - $670,357
4,932 Added 12.17%
45,444 $5.84 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $1.28 Million - $1.54 Million
14,566 Added 56.14%
40,512 $4.19 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $1.08 Million - $2.36 Million
11,833 Added 83.84%
25,946 $2.36 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $526,744 - $583,039
3,377 Added 31.45%
14,113 $2.28 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $8,072 - $9,707
61 Added 0.57%
10,736 $1.71 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $28,919 - $38,163
-282 Reduced 2.57%
10,675 $1.44 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $72,508 - $88,983
761 Added 7.46%
10,957 $1.09 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $827,571 - $976,428
8,016 Added 367.71%
10,196 $1.14 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $25,043 - $30,273
-269 Reduced 10.98%
2,180 $242,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $2,876 - $3,512
-30 Reduced 1.21%
2,449 $274,000
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $27,520 - $34,758
-326 Reduced 11.62%
2,479 $238,000
Q2 2021

Aug 16, 2021

SELL
$67.66 - $84.76 $15,358 - $19,240
-227 Reduced 7.49%
2,805 $235,000
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $11,400 - $12,889
-170 Reduced 5.31%
3,032 $204,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $23,883 - $26,332
-375 Reduced 10.48%
3,202 $222,000
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $6,907 - $8,016
-118 Reduced 3.19%
3,577 $234,000
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $5,935 - $7,773
120 Added 3.36%
3,695 $222,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $169,955 - $191,012
3,575 New
3,575 $185,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Capital International, Inc. Portfolio

Follow Capital International, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.